Return on Equity (ROE) is 20.0. It is considered good, since it is above 15%Gross Profit Margin (GPM) is 75.2. It is considered good, since it is above 20%Operating Profit Margin (OPM) is 30.0. It is considered good, since it is above 15%Net Profit Margin (NPM) is 30.0. It is considered good, since it is above 10%Price to Earnings Growth (PEG) ratio is 4.5. It is considered under valued, since it is PEG is below 5EPS follows V pattern. EPS value of the company was decreasing but now it is increasing for last few quaters. In the last quater the EPS is increasing. Torrent Pharmaceuticals Ltd's EPS is lower than its peers.Net Profit follows V pattern. Net Profit value of the company was decreasing but now it is increasing for last few quaters. In the last quater the Net Profit is increasing.EBIT follows V pattern. EBIT value of the company was decreasing but now it is increasing for last few quaters. In the last quater the EBIT is increasing. Torrent Pharmaceuticals Ltd's EPS is greater than its peers.Revenue follows M (fluctuating) pattern. Revenue value of the company is increasing and decreasing for every alternate quater respectively. In the last quater the Revenue is increasing.The Debt-To-Equity is 0.67. As it lies between the moderate range of 0.5 and 1. It implies that the company is using a mix of debt and equity for financing.The Interest coverage ratio is 5.82. As the value is more than 1.75. It is considered good.The working capital turnover ratio of 3.788. As the value is more than 2. It is considered really good.The Asset turnover is 0.7. As the value is less than 1, it is considered poor.Cash from investing activity follows M (fluctuating) pattern. Cash from investing activity value of the company is increasing and decreasing for every alternate year respectively. In the last year the Cash from investing activity is decreasing.Cash from operating activity follows M (fluctuating) pattern. Cash from operating activity value of the company is increasing and decreasing for every alternate year respectively. In the last year the Cash from operating activity is increasing.Cash from financing activity value of the company is increasing in the last year. In the last year the Cash from financing activity is increasing. Torrent Pharmaceuticals Ltd's total assets is greater than its peers.The PE Ratio is 62.3 Since the PE_Ratio is above 20, the stock is Over valuedThe Price to Book Ratio is 12.5 Since the price to Book Ratio is over 1 the stock is Over valuedThe Price to Sales Ratio is 8.18 Since the Price to Sales ratio is more than 1.8, the stock is OvervaluedThe Dividend yield is 0.89 Since the Dividend Yield is less than 1.0 the stock is UndervaluedThe ROCE is 19.8 Since the ROCE is between 15 and 20 it is Above AverageThe EV/EBITDA is 28.0 Since the EV/EBITDA ratio is more than 3.0 the stock is OvervaluedThe EV/EBITDA is 28.0 Since the EV/EBITDA ratio is more than 3.0 the stock is OvervaluedThe Quick Ratio is 0.62 Since the Quick Ratio is less, the stock is Critical: Immediate Attention NeededThe Current Ratio is 1.08Since the Current Ratio is less, the stock is Critical: Immediate Attention Needed